World Vaccine Manufacturing Congress Asia Day Two - 13 June 2012

last modified: 24 May '12

Please enable javascript to see more information on speakers

08.30
Registration and refreshments
08.50
Chairman’s opening remarks

VACCINE REGULATIONS AND COMMERCIALISATION IN ASIA

09.00
Concept to commercialisation: A case study of Rabies vaccine development
Mr Pradip Patel at World Vaccine Congress Asia 2012

  • Overcoming research and development issues involved in producing a Rabies vaccine
  • Understanding regulatory requirements for vaccine development
  • Discovering important factors in facility design and Scale Up: Pilot scale manufacturing to large scale manufacturing
     

09.30
Building a cGMP compliant vaccine manufacturing plant in Thailand
Ms Patchara Kootiratrakarn at World Vaccine Congress Asia 2012

Ms Patchara Kootiratrakarn

Patchara KOOTIRATRAKARN, Head Pharmacist, Director of Department of Regulatory Affairs, Pharmacovigilance and Business Operations at GPO-MBP Co., Ltd., graduated from Mahidol University, Bachelor degree of Pharmacy in 1978 and Master degree of...

more..

  • Understanding the challenges in building a cGMP compliant manufacturing facility in Thailand
  • Emphasizing on regulatory and quality assurance in your manufacturing operational plan
  • Case study: Building a plant while managing compliance and technical issues in Thailand
     

10.00
Morning refreshments, exhibition viewing, academic poster showcase and on-floor demo

UPSTREAM, DOWNSTREAM PROCESSING & SINGLE USE TECHNOLOGY

11.00
Developing effective production strategies for multi-vaccine manufacturing in Asia
Mr Günter Jagschies at World Vaccine Congress Asia 2012

  • Evaluating specific challenges associated with manufacturing different vaccines
  • Developing robust approaches to fully utilise production facility
  • Exploring the different strategies available for ensuring quality control and regulatory compliance
     

11.30
Transitioning existing biologics processes into single use technology platform to enable global deployment
Dr I-Teh Tong at World Vaccine Congress Asia 2012

Dr I-Teh Tong

Dr. I-Teh Tong is the Director of Vaccines & Biologics Business Operations at Merck & Co., Inc. He joined Merck in 1992 after receiving his Ph.D. in Chemical Engineering from the University of Wisconsin. He has 20 years experience in vaccine and...

more..

  • Factors to consider before implementation: performance equivalency, quality, logistics and business needs
  • Evaluating which single-use equipment to utilize, considering cost and which stage should be implemented first
  • Examining before and after implementation for optimum efficiency
     

12.00
Networking luncheon, exhibition viewing, academic poster showcase and on-floor demo

BIOPROCESS DEVELOPMENT

14.00
Pilot scale production of highly efficacious and stable Enterovirus 71 vaccine candidate
Dr Pele Chong at World Vaccine Congress Asia 2012

Dr Pele Chong

Dr. Chong had spent 15 years at Sanofi Pasteur in human vaccine research and development. During his tenure there, Dr. Chong had developed two human vaccines, ProHibit against H. influenzae type b and the component pertussis vaccine, and also took a ...

more..

  • Challenges in R&D and production of a vaccine for EV71, cause of several HFMD epidemics in Asia
  • Optimising the manufacturing process of the serum-free cell-based EV71 vaccine
  • Capitalising on stability studies of EV71 vaccine with efficacious response in mice, rats, rabbits, and non-human primates to support clinical trials and technology transfer processes
     

14.30
Overcoming polysaccharide conjugate vaccine development and manufacturing challenges in Asia

  • Identifying key considerations in process design and technologies for polysaccharide conjugate vaccine development
  • Meeting operational and compliance standards to bring vaccine to market in Asia
  • Strategy in overcoming complexities of polysaccharide conjugate vaccine production
     

    15.00
    Afternoon refreshments, exhibition viewing, academic poster showcase and on-floor demo

    EXECUTIVE ROUNDTABLE LEADERSHIP DISCUSSIONS

    16.00
    Theme: Managing your strategic vaccine manufacturing partnerships in Asia

    The roundtable discussions are highly interactive meetings intended for stakeholders of the vaccine space in Asia to discuss about pertinent industrial processes and how to optimize the productivity and potential of vaccine manufacturing partnerships with regional and international counterparts. It is an excellent opportunity for pharmas, biotechs and contract manufacturing organisations to connect with their peers in the industry.

    Roundtable discussions focused on the theme of building sustainable & strategic partnerships will be hosted by senior level executives of leading biopharmaceutical companies & contract manufacturing organizations:

    Theme: Managing your strategic vaccine manufacturing partnerships in Asia

    • Uncovering opportunities & challenges in vaccine manufacturing in Asia
    • Capitalising on best practices & partnership integration strategies of Asian vaccine manufacturers
    • Collaborating with your Asian manufacturing partners for improved operational efficiency

      17.00
      Chairman’s closing remarks
      17.05
      End of conference day two

      Register for World Vaccine Congress Asia 2012 ›

      Get the World Vaccine Congress Asia 2012 brochure ›

      Back to top ›

      last modified: 24 May '12

      Developing effective production strategies for multi-vaccine manufacturing in Asia

      • Evaluating specific challenges associated with manufacturing different vaccines
      • Developing robust approaches to fully utilise production facility
      • Exploring the different strategies available for ensuring quality control and regulatory compliance

      Growing vaccine pipeline value through effective partnering and investment strategies in Asia

      Asia contains a wide variety of vaccine markets, each with different advantages due to cultural, economic and geographic differences. Identifying the right partners to develop vaccines from initial R&D through trials to commercialization requires a strategic and well defined approach.
      This workshop will assist participants in understanding how to approach the Asian market for external research and development and how to successfully build a pipeline through strategic partnerships.

      Transitioning existing biologics processes into single use technology platform to enable global deployment

      • Factors to consider before implementation: performance equivalency, quality, logistics and business needs
      • Evaluating which single-use equipment to utilize, considering cost and which stage should be implemented first
      • Examining before and after implementation for optimum efficiency

      Optimising cost-effective Japanese Encephalitis (JE) vaccine development in Asia

      • Evaluating current development on inactivated and live molecular JE vaccine for the global population
      • Tapping on lessons learnt from producing the vaccine in Asia
      • Case study: Assessing the long term immunity of live attenuated Japanese encephalitis chimeric virus vaccine

      Innovative vaccine design: Important chemistry, manufacturing and controls (CMC) issues in adjuvant development

      • Uncovering new concepts and knowledge about innovative vaccine design; innate immunity and beyond
      • Tapping on advanced technologies of immune-manipulation and delivery system in Japan
      • Overcoming regulatory hurdles and harnessing the potential for adjuvants in Japan; key factors for very safe and efficacious vaccines

      Innovative International Vaccine Developments

      Leading global and Asian biotechs, pharmas and research institutes will showcase their latest vaccine developments looking for potential partners globally and across Asia. Potential partnerships run from research and development to licensing and collaboration in vaccine commercialization.

      sponsor World Vaccine Congress Asia 2012 ›

      Sponsors
      Platinum sponsor
      GE Healthcare at World Vaccine Congress Asia 2012
      Gold Sponsor
      Merck Millipore at World Vaccine Congress Asia 2012
      Silver Sponsor
      Medicago Inc at World Vaccine Congress Asia 2012
      Bronze sponsor
      Finesse Solutions, LLC at World Vaccine Congress Asia 2012
      Bronze Sponsor
      ViroClinics Biosciences B.V. at World Vaccine Congress Asia 2012
      Innovative showcase sponsor
      Bavarian Nordic A/S at World Vaccine Congress Asia 2012
      Innovative biotech showcase sponsor
      Immune Targeting Systems (ITS) Ltd at World Vaccine Congress Asia 2012

      sponsors list ›